neuromyelitis optica spectrum disorder
Showing 1 - 25 of 32
Neuromyelitis Optica Spectrum Disorder, NMOSD, AQP4+ NMOSD Trial
Not yet recruiting
- Neuromyelitis Optica Spectrum Disorder
- +2 more
- (no location specified)
Jul 21, 2023
Neuromyelitis Optica Spectrum Disorder Exposed to UPLIZNA®
Not yet recruiting
- Neuromyelitis Optica Spectrum Disorder
- Pregnancy Related
- (no location specified)
Jun 9, 2023
Inebilizumab in Acute Neuromyelitis Optica Spectrum Disorders
Not yet recruiting
- Neuromyelitis Optica Spectrum Disorder
- Inebilizumab
- oral immunosuppressant
- (no location specified)
Jun 5, 2023
Neuromyelitis Optica Spectrum Disorder Trial in Worldwide (Inebilizumab)
Recruiting
- Neuromyelitis Optica Spectrum Disorder
-
La Jolla, California
- +14 more
Jan 25, 2023
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Neuromyelitis Optica Spectrum Disorder Trial in Wuhan (CT103A
Recruiting
- Autoimmune Diseases
- +5 more
- CT103A cells
- Cyclophosphamide and fludarabine
-
Wuhan, Hubei, ChinaTongji Hospital affiliated to Tongji Medical College of Huazhong
Dec 10, 2022
Neuromyelitis Optica, Neuromyelitis Optica Spectrum Disorder, NMO Spectrum Disorder Trial in Tianjin (Daratumumab, Placebo)
Recruiting
- Neuromyelitis Optica
- +2 more
- Daratumumab
- Placebo
-
Tianjin, Tianjin, ChinaTianjin Medical University General Hospital
Oct 19, 2022
Immune Cells and Meningeal Lymphatic Drainage in Demyelinating
Recruiting
- Multiple Sclerosis
- +2 more
-
Tianjin, Tianjin, ChinaTianjin Medical University General Hospital
Oct 19, 2022
Neuromyelitis Optica Spectrum Disorder Trial (Mitoxantrone Hydrochloride Liposome Injection)
Not yet recruiting
- Neuromyelitis Optica Spectrum Disorder
- Mitoxantrone Hydrochloride Liposome Injection
- (no location specified)
Sep 20, 2022
Neuromyelitis Optica, Neuromyelitis Optica Spectrum Disorder Trial in Worldwide (eculizumab)
Completed
- Neuromyelitis Optica
- Neuromyelitis Optica Spectrum Disorder
- eculizumab
-
Scottsdale, Arizona
- +68 more
Jul 25, 2022
Neuromyelitis Optica Spectrum Disorder, NMOSD Trial in Le Kremlin-bicêtre, Gdansk (Satralizumab)
Recruiting
- Neuromyelitis Optica Spectrum Disorder
- NMOSD
-
Le Kremlin-bicêtre, France
- +1 more
Aug 17, 2022
Neuromyelitis Optica Spectrum Disorder Trial in Xi'an (Ofatumumab)
Recruiting
- Neuromyelitis Optica Spectrum Disorder
-
Xi'an, Shaanxi, ChinaTangdu Hospital
Aug 16, 2022
Neuromyelitis Optica Spectrum Disorder Trial in Barcelona (Ravulizumab)
Recruiting
- Neuromyelitis Optica Spectrum Disorder
-
Barcelona, SpainClinical Trial Site
Jul 6, 2022
Neuromyelitis Optica Spectrum Disorder Trial in Beijing (MIL62, Placebo)
Not yet recruiting
- Neuromyelitis Optica Spectrum Disorder
- MIL62
- Placebo
- (no location specified)
May 26, 2022
Rare Neuroimmunologic Disorders
Recruiting
- Neuromyelitis Optica
- +3 more
-
Dallas, TexasThe University of Texas Southwestern Medical Center
May 9, 2022
Sclerosis, Multiple, Neuromyelitis Optica Spectrum Disorder, Myelin Oligodendrocyte Glycoprotein (MOG)-Antibody Related
Recruiting
- Sclerosis, Multiple
- +3 more
- No intervention
-
Amiens, France
- +33 more
Mar 21, 2022
Neuromyelitis Optica Spectrum Disorder Trial in Worldwide (satralizumab, azathioprine (AZA), mycophenolate mofetil (MMF))
Active, not recruiting
- Neuromyelitis Optica Spectrum Disorder
- satralizumab
- +3 more
-
Birmingham, Alabama
- +52 more
Mar 16, 2022
Neuromyelitis Optica Spectrum Disorder Trial in Beijing (Orelabrutinib)
Not yet recruiting
- Neuromyelitis Optica Spectrum Disorder
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital, Chinese Academy of Medica
Mar 16, 2022
Neuromyelitis Optica, Neuromyelitis Optica Spectrum Disorder Trial in Worldwide (Ravulizumab)
Active, not recruiting
- Neuromyelitis Optica
- Neuromyelitis Optica Spectrum Disorder
- Ravulizumab
-
Birmingham, Alabama
- +67 more
Feb 3, 2022
Maintenance Plasma Exchange for Neuromyelitis Optica
Completed
- Neuromyelitis Optica
- +2 more
- Plasma exchange (PLEX)
-
Scottsdale, Arizona
- +1 more
Dec 7, 2021
Optic Neuritis, Transverse Myelitis, Acute Disseminated Encephalomyelitis Trial in Switzerland
Recruiting
- Optic Neuritis
- +16 more
-
Aarau, Aargau, Switzerland
- +11 more
Aug 18, 2021
Neuromyelitis Optica Spectrum Disorder Trial in Waltham
Enrolling by invitation
- Neuromyelitis Optica Spectrum Disorder
-
Waltham, MassachusettsCorrona, LLC
May 10, 2021
Clinical Patterns of Neuromyelitis Optica Spectrum Disorders in
Completed
- Neuromyelitis Optica Spectrum Disorder
- serum aquaporin 4 antibody (AQP-4-Ab)
- +2 more
-
Assiut, EgyptAssiut University Hospital
Nov 5, 2020
Neuromyelitis Optica Spectrum Disorder Trial in Isfahan (Azathioprine, Rituximab)
Completed
- Neuromyelitis Optica Spectrum Disorder
-
Isfahan, Iran, Islamic Republic ofKashani Hospital
Sep 29, 2020
Neuromyelitis Optica Spectrum Disorder Trial in Beijing (Corticosteroids & tanCART19/20)
Withdrawn
- Neuromyelitis Optica Spectrum Disorder
- Corticosteroids & tanCART19/20
-
Beijing, Beijing, ChinaPeople's Liberation of Army General Hospital (PLAGH)
Sep 17, 2019